FDA Inspection
Somerset Therapeutics LimitedSomerset Therapeutics Limited – FDA Inspection, Apr 4, 2022
Record Details
This FDA Inspection record concerns Somerset Therapeutics Limited, with an inspection on April 4, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 4, 2022
- Product Type
- Drugs
View Company Profile
ID · 81ffbd04-e1df-4ac2-a152-50b2ecde316a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1166834
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Somerset Therapeutics Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 21, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 19, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 23, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Somerset Therapeutics Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.